INFLAMMATIX
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University. The company was founded by Timothy Sweeney and Jonathan Romanowsky in California.
INFLAMMATIX
Industry:
Big Data Bioinformatics Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.inflammatix.com
Total Employee:
51+
Status:
Active
Contact:
650-443-3030
Email Addresses:
[email protected]
Total Funding:
137.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
CareDx
CareDx is a novel molÂeÂcÂuÂlar diagnosÂtics comÂpany.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Inflammatix
OSF Ventures
OSF Ventures investment in Series D - Inflammatix
D1 Capital Partners
D1 Capital Partners investment in Series D - Inflammatix
Think.Health
Think.Health investment in Series D - Inflammatix
Northpond Ventures
Northpond Ventures investment in Series D - Inflammatix
Khosla Ventures
Khosla Ventures investment in Series D - Inflammatix
DARPA
DARPA investment in Grant - Inflammatix
Northpond Ventures
Northpond Ventures investment in Series C - Inflammatix
Grey Sky Venture Partners
Grey Sky Venture Partners investment in Series C - Inflammatix
Khosla Ventures
Khosla Ventures investment in Series C - Inflammatix
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-15 | Inflammatix Appoints Purvesh Khatri as Chief Scientific Officer |
| 2021-04-15 | Inflammatix Appoints Amy Boyle as Chief Operating Officer |
Official Site Inspections
http://www.inflammatix.com Semrush global rank: 4.62 M Semrush visits lastest month: 2.17 K
- Host name: 163.0.153.160.host.secureserver.net
- IP address: 160.153.0.163
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Inflammatix"
About Inflammatix and our team
Inflammatix is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. Pipeline. TriVerity; ... (CEO) of …See details»
Inflammatix - Crunchbase Company Profile & Funding
Inflammatix may be growing as it has completed the development of a diagnostic tool for acute infection and sepsis, indicating progress in product development. Furthermore, the company has secured a USD 6.0 million contract with the …See details»
Inflammatix, Inc. - LinkedIn
Inflammatix, Inc. | 6,890 followers on LinkedIn. We’re reimagining diagnostics by reading the immune system | Inflammatix is developing an innovative point-of-care instrument platform to be used ...See details»
Inflammatix - Funding, Financials, Valuation & Investors
Inflammatix develops rapid immune system diagnostics to improve patient care and public health. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
The Promise of Interpreting Immune Response
Click Continue to leave hostresponsedx.com and visit inflammatix.com. Continue Cancel. THE PROMISE OF INTERPRETING THE ... ORGANIZATION. COMMENTS. References. Filice …See details»
Inflammatix - Contacts, Employees, Board Members, Advisors
Organization. Inflammatix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Inflammatix has 9 current employee …See details»
Inflammatix | Education on the power of interpreting …
At Inflammatix ML, we understand that bringing world-class ID diagnostics to the point of care demands a holistic approach. Our highly interdisciplinary team draws on decades of experience in academic and industrial science with …See details»
Sepsis Alliance Institute: Inflammatix - Sepsis Luminary
Inflammatix, Inc., a pioneering molecular diagnostics company headquartered in Sunnyvale, ... Sepsis Alliance is a tax-exempt organization under Sections 501(c)(3) of the Internal Revenue …See details»
Inflammatix collects $57M as it awaits FDA review of infectious …
Sep 12, 2024 Inflammatix previously raised $102 million in its 2021 series D financing, aimed at supporting its clinical development programs. The company’s pipeline also includes a separate …See details»
Inflammatix - Updates, News, Events, Signals & Triggers
Inflammatix may be growing as it has completed the development of a diagnostic tool for acute infection and sepsis, indicating progress in product development. Furthermore, the company …See details»
Inflammatix Sponsored Webinar: Advances in Emergency Medicine ...
Sam Ajizian, MD, came to Inflammatix as Chief Medical Officer after nearly 10 years at Medtronic, serving in CMO roles in the Acute Care & Monitoring businesses. He oversaw a global …See details»
Inflammatix Adds Three MedTech Industry Veterans to Executive ...
Oct 10, 2024 Inflammatix product development has been funded in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for …See details»
Inflammatix Receives Breakthrough Device Designation from FDA …
Nov 28, 2023 Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device …See details»
Inflammatix Initiates TriVerity™ for Improved Management of …
Nov 11, 2024 Inflammatix product development has been funded in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for …See details»
Inflammatix | Groundbreaking tests to address unmet needs
Inflammatix has been at the forefront of sepsis subtypes (or ‘endotypes’) research in transcriptomics, with a classifier that has been validated 4,5 in research settings to produce …See details»
Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute …
Nov 28, 2023 Inflammatix has enrolled about 1,000 of the 1,500 patients for its Sepsis-Shield study that will analyze gene expression and other laboratory data derived from samples of …See details»
Inflammatix Adds Three MedTech Industry Veterans to Executive ...
Oct 10, 2024 Inflammatix product development has been funded in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for …See details»
Inflammatix | Evidence that supports our mission
Our efforts in developing diagnostic tests have been extensively validated and published in top-tier medical publications and presented at key medical society meetings.See details»
Inflammatix Preps Immune-Response Sepsis Dx for FDA Clinical
Aug 16, 2019 Inflammatix can expect competition from a number of established diagnostic companies marketing products for sepsis diagnosis. For example, several FDA-cleared …See details»